Biotech stocks offered a mixed third-quarter bag on Thursday, with Arcutis reversing and BeOne Medicines surging deeper into its buy zone.
The post Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch?
Appeared first on Investor's Business Daily .